February 2020

Diagnostic Stewardship: Beyond Managing Bloodstream Infections

February 21, 2020

Stewardship & Prevention

Diagnostic stewardship is a novel concept related to modifying the process of ordering, testing, and reporting with the goal of decreasing unnecessary testing and treatment, working upstream and synergistically with antimicrobial stewardship principles.

Five Ways ID Clinicians Can Take On Antibiotic Resistance: Highlights From the CDC's Latest Report

February 18, 2020

Emerging & Re-Emerging Infections

A death from an antibiotic-resistant infection occurs about every 15 minutes in the United States. The CDC’s 2019 threat report dives into national infection estimates and actions we can take to combat this threat.

Imipenem-Cilastatin-Relebactam: Imipenem Is Rele Back Again

February 13, 2020

News and Breakthroughs

The US Food and Drug Administration approved imipenem-cilastatin-relebactam to treat complicated intra-abdominal infections and complicated urinary tract infections in adults with limited treatment options.

Consider the MIC: Treating Respiratory Infections Caused by Pseudomonas aeruginosa With Ceftolozane/Tazobactam

February 12, 2020

In the Literature

When using ceftolozane/ tazobactam to treat patients with P aeruginosa respiratory tract infections, the use of extended or continuous antibiotic infusion and/or combination therapy with other active antibiotic agents should be considered, particularly if targeting higher MIC values.

Can Improving Penicillin Allergy Documentation Cut Costs?

December 18, 2019

Meeting Coverage

A team of pharmacists at Baptist Hospital reported that improving penicillin allergy documentation and increasing the use of β-lactams had potential cost savings of $21,468 over a 3-month period.

Speed of Processing Training Resulted in Significant Improvements for Individuals With HAND

November 08, 2019

Meeting Coverage

There is a vast unmet need for non-pharmacological treatment strategies to protect and improve cognitive function in the approximately 50% of adults living with HIV who experience HIV-associated neurocognitive disorder.